clorazepate dipotassium

Generic: clorazepate dipotassium

Labeler: taro pharmaceuticals u.s.a., inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name clorazepate dipotassium
Generic Name clorazepate dipotassium
Labeler taro pharmaceuticals u.s.a., inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

clorazepate dipotassium 15 mg/1

Manufacturer
Taro Pharmaceuticals U.S.A., Inc.

Identifiers & Regulatory

Product NDC 51672-4044
Product ID 51672-4044_22e382fc-edce-24b7-e063-6394a90a35e6
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075731
DEA Schedule civ
Listing Expiration 2026-12-31
Marketing Start 2000-04-27

Pharmacologic Class

Classes
benzodiazepine [epc] benzodiazepines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516724044
Hyphenated Format 51672-4044

Supplemental Identifiers

RxCUI
197464 197465 197466
UPC
0351672404314
UNII
63FN7G03XY

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name clorazepate dipotassium (source: ndc)
Generic Name clorazepate dipotassium (source: ndc)
Application Number ANDA075731 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 15 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (51672-4044-1)
  • 500 TABLET in 1 BOTTLE (51672-4044-2)
  • 1000 TABLET in 1 BOTTLE (51672-4044-3)
source: ndc

Packages (3)

Ingredients (1)

clorazepate dipotassium (15 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "22e382fc-edce-24b7-e063-6394a90a35e6", "openfda": {"upc": ["0351672404314"], "unii": ["63FN7G03XY"], "rxcui": ["197464", "197465", "197466"], "spl_set_id": ["499a6989-8912-44b7-b1eb-ee8f85ae378f"], "manufacturer_name": ["Taro Pharmaceuticals U.S.A., Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (51672-4044-1)", "package_ndc": "51672-4044-1", "marketing_start_date": "20000427"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (51672-4044-2)", "package_ndc": "51672-4044-2", "marketing_start_date": "20000427"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (51672-4044-3)", "package_ndc": "51672-4044-3", "marketing_start_date": "20000427"}], "brand_name": "Clorazepate Dipotassium", "product_id": "51672-4044_22e382fc-edce-24b7-e063-6394a90a35e6", "dosage_form": "TABLET", "pharm_class": ["Benzodiazepine [EPC]", "Benzodiazepines [CS]"], "product_ndc": "51672-4044", "dea_schedule": "CIV", "generic_name": "Clorazepate Dipotassium", "labeler_name": "Taro Pharmaceuticals U.S.A., Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Clorazepate Dipotassium", "active_ingredients": [{"name": "CLORAZEPATE DIPOTASSIUM", "strength": "15 mg/1"}], "application_number": "ANDA075731", "marketing_category": "ANDA", "marketing_start_date": "20000427", "listing_expiration_date": "20261231"}